FIELD: chemistry.
SUBSTANCE: method of producing a granulate of metformin hydrochloride and inulin by granulation, involving sieving metformin hydrochloride and inulin, mixing metformin hydrochloride and inulin, granulation, drying, characterized by that metformin hydrochloride and inulin are sieved through sieves with a hole diameter of 0.2 mm, after which a binder solution is prepared by dissolving inulin in purified water with concentration of 5 to 25 wt.%, then at room temperature metformin hydrochloride and inulin are mixed at a ratio of metformin hydrochloride : inulin equal to 250-1000 mg : 50-500 mg, respectively, with 5-25 wt.% water solution of inulin with weight ratio of mixture of inulin and metformin hydrochloride : inulin solution equal to 311.25-1522.5 mg : 45-225 mg, in a mixer with a paddle mixer at revolutions from 50 to 100 per minute until uniform mixing for 5 to 10 minutes, obtained mass is granulated by wet granulation by rubbing the obtained mass through perforated sieves with a hole diameter of 1 mm, after which produced granulate is dried at temperature of 40 °C to residual moisture content equal to 1.3-4.76 wt.%.
EFFECT: disclosed is a method of producing granules of metformin hydrochloride and inulin by granulation.
1 cl, 2 dwg, 7 ex
Title | Year | Author | Number |
---|---|---|---|
NEW COMPOSITION | 2006 |
|
RU2821230C2 |
NOVEL COMPOSITION | 2006 |
|
RU2483716C2 |
PROLONGED PHARMACEUTICAL COMPOSITION DRUG FORM AND METHOD OF ITS PRODUCTION (VERSIONS) | 2009 |
|
RU2435584C2 |
SOLID INDIVIDUAL HIGH 2-ETHYL-6-METHYL-3-PYRIDIN-3-OLE HYDROCHLORIDE DOSAGE FORM AND METHOD FOR PREPARING IT | 2010 |
|
RU2448686C1 |
PHARMACEUTICAL COMPOSITIONS FOR TREATING CEREBROVASCULAR DISORDERS AND METHODS FOR PREPARING THEM | 2012 |
|
RU2559776C2 |
PHARMACEUTICAL COMPOSITION OF METFORMIN WITH PROLONGED RELEASE AND METHOD OF ITS OBTAINING | 2006 |
|
RU2433821C2 |
PHARMACEUTICAL COMPOSITIONS WITH PROLONGED RELEASE FOR TREATING CEREBROVASCULAR DISORDERS | 2014 |
|
RU2611339C2 |
MACOZINONE-BASED PHARMACEUTICAL COMPOSITION FOR TREATMENT OF TUBERCULOSIS INCLUDING MULTI- AND EXTENSIVELY DRUG-RESISTANT FORMS THEREOF | 2020 |
|
RU2751163C1 |
COMBINATION FOR TREATMENT OF DIABETES AND COMPLICATIONS THEREOF | 2011 |
|
RU2451506C1 |
PHARMACEUTICAL COMPOSITION SHOWING ANALGETIC, ANTI-INFLAMMATORY, ANTIPYRETIC AND SPASMOLYTIC EFFECT | 2001 |
|
RU2183116C1 |
Authors
Dates
2025-05-06—Published
2024-07-29—Filed